Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: August 4, 2026 at 6:56 PM UTC
| NCT Number | NCT07734493 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE1 |
| Target Enrollment | 90 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Leal Therapeutics, Inc |
| Last Updated on CT.gov | August 4, 2026 (18 hours ago) |
As of August 4, 2026: Clinical trial NCT07734493 is currently recruiting participants. This phase1 study for schizophrenia is actively seeking new participants at 10 locations across the United States. The study is sponsored by Leal Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07734493 is actively recruiting participants as of August 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07734493 was last updated 18 hours ago (August 4, 2026). HelloStudys verifies this status automatically.